✓ Revise Right course
A placebo is a fake pill that looks identical to the real drug but contains no active ingredient. Free GCSE AQA notes with key terms and 12 questions answered.
Clinical trials and finding the right dose is part of Communicable diseases in GCSE AQA Higher Biology.
4 min
Reading time
17
Lessons in this topic
GCSE AQA Higher
Pathway
Reviewed by Revise Right
Content review
A placebo is a fake pill that looks identical to the real drug but contains no active ingredient. Free GCSE AQA notes with key terms and 12 questions answered.
AQA GCSE Biology mock draft, 26–31 Oct. Draft coverage: Biology Paper 1 (Higher tier). Reviewed for an original-practice sitting; check student availability before registering. Marking and results will follow later, after separate approval. Eligible new accounts receive a five-day Pro trial when signup email verification completes. Previous trials keep their original expiry. After expiry, new papers need Pro unless you have an explicitly confirmed free sitting offer for this event. That offer adds no Pro time or AI learning. Saved attempts and released results remain readable. No card or automatic charge.
Use this lesson to stay inside Communicable diseases while connecting the detail back to the wider Infection and response topic.
Read the core explanations from Clinical trials and finding the right dose before testing yourself from memory.
Imagine you're testing a new painkiller. Would you give patients a massive dose on day one? That's like jumping into the deep end without checking if you can swim.
Clinical trials always begin with very low doses of the drug. This isn't being cautious for the sake of it — it's about keeping people alive. Even drugs that seem safe in laboratory tests can cause unexpected reactions in humans.
Think of it like testing water temperature with your toe before diving in. Researchers start with doses so low they might not even work — but that's the point. They're looking for the highest dose that doesn't cause harmful side effects.
Once researchers confirm the drug is safe at low doses, they face a new challenge: finding the optimum dose. Too little and the drug won't work. Too much and side effects outweigh the benefits.
This is where Phase II and III trials come in. If the drug passes the safety test, further clinical trials gradually increase the dose. Researchers carefully monitor both effectiveness and side effects at each level.
Worked example: How Researchers Find the Optimum Dose
A new antibiotic shows promise. How do researchers determine the best dose?
Answer: The optimum dose is 40mg daily — high enough to be effective, low enough to be safe
The optimum dose isn't always the highest safe dose. Sometimes a lower dose works just as well with fewer side effects. It's about finding the minimum effective dose, not the maximum tolerated dose.
Here's where clinical trials get clever. In double blind trials, some patients receive a placebo — a fake pill that looks identical to the real drug but contains no active ingredient.
This might seem cruel, but it's essential for accurate results. The human mind is powerful — people often feel better just because they think they're getting treatment. This is called the placebo effect.
Without a placebo group, researchers can't tell if improvements are due to the drug or just patients' expectations. The drug must work better than the placebo to be considered effective.
Double blind trials are the gold standard because they eliminate two types of bias. Patient bias occurs when people feel better because they expect to. Doctor bias happens when researchers unconsciously favour patients they know are getting the real treatment.
By keeping everyone 'blind' to who gets what, the trial results reflect the drug's true effects, not psychological influences. Only after all data is collected do researchers reveal who had the drug and who had the placebo.
Exam questions on clinical trials often test your understanding of why each step matters. Don't just memorise the process — understand the reasoning behind each phase.
Exam depth extension: In clinical trials and finding the right dose, connect why start small? the safety-first approach to finding the sweet spot: optimum dose discovery using clear cause-and-effect statements. When you explain biological processes, include what changes, why it changes, and the consequence for cells, organisms, or populations. If calculations appear, show each step, include units, and end with a sentence that interprets the result in biological context.
Common exam mistake: Students often say placebos are 'unfair' to patients. Actually, all patients in trials are volunteers who understand some might receive placebos. This is ethical because we need accurate data to help future patients.
Published by Revise Right. Use the official specification reference to check the requirements for your course. Content updated: 2026-03-20.
Move to the related lessons or back to the topic page when you need the wider sequence before exam-style practice.
A placebo is a fake pill that looks identical to the real drug but contains no active ingredient. It is used because without a placebo group researchers cannot tell if improvements are due to the drug or just patients' expectations; the drug must work better than the placebo to be considered effective.
The placebo effect is the improvement in symptoms that occurs because a patient believes they are receiving treatment. People often feel better just because they think they are getting treatment, which is why trials compare the drug with a placebo.
A double blind trial is a clinical trial in which neither the patients nor the doctors know who is getting the real drug and who is getting the placebo. This eliminates patient bias and doctor bias; only after all data is collected do researchers reveal who had the drug.
Placebos are used in drug trials because people often feel better just because they think they are getting treatment. Without a placebo group, researchers cannot tell if improvements are due to the drug or patients' expectations, and the drug must work better than the placebo to be considered effective.
Double blind trials are the gold standard because they remove two types of bias: patient bias, where people feel better because they expect to, and doctor bias, where researchers unconsciously favour patients getting the real treatment. Nobody knows who has the drug until all data is collected.
Giving placebos in trials is considered ethical because all patients in trials are volunteers who understand some might receive placebos. Accurate data is needed to help future patients, so calling placebos 'unfair' is a common mistake.
Clinical trials start with very low doses because even drugs that seem safe in laboratory tests can cause unexpected reactions in humans. In Phase I, very small doses are given to check for safety and side effects, looking for the highest dose that does not cause harmful side effects.
The optimum dose is found by using Phase I results to set the maximum safe dose, then giving different groups different doses and comparing effectiveness and side effects. In one example, 40mg daily cleared 95% of infections with minimal side effects, so it became the recommended dose: the minimum effective dose, not the maximum tolerated dose.
In a Phase I clinical trial, very small doses of the drug are given to check for safety and side effects. Researchers start with doses so low they might not even work, looking for the highest dose that does not cause harmful side effects.
The optimum dose of a drug is the dose that gives maximum benefit with acceptable risk: high enough to be effective, low enough to be safe. It is not always the highest safe dose, because a lower dose may work just as well with fewer side effects.
In a double blind trial, neither the patients nor the doctors know who is getting the real drug and who is getting the placebo. This eliminates both patient bias and doctor bias, so the results reflect the drug's true effects rather than psychological influences.
Researchers compare doses by giving different groups different doses, such as 10mg, 20mg, 40mg and 60mg daily, and tracking both effectiveness and side effects. If 40mg clears 95% of infections with minimal side effects, that becomes the recommended dose.